Life Length

lifelength.com ↗ ·Madrid ·Series A

Life Length is a Madrid-based biotechnology company specialising in telomere and telomerase measurement and telomere-based diagnostics. It was founded in 2010 as a spin-off of the Spanish National Cancer Research Centre (CNIO) to commercialise the Telomere Analysis Technology (TAT) developed by María Blasco, which measures short telomeres chromosome by chromosome in individual cells of blood and tissue samples. The company sells testing services to pharmaceutical and biotech companies for drug R&D and clinical trials, and to the public through physicians and clinics offering biological-age and health indicators; its products include a prostate cancer diagnostic approved in 2022 and the HEALTHTAV test, and it runs a CLIA-certified laboratory in the Madrid area. Its founding capital came from María Blasco, the Botín Foundation and Matlin Associates, and it has since received non-dilutive funding, including €3.1 million from the EU's Horizon 2020 programme for the ONCOCHECK cancer-biomarker project in 2017.

Founded
2010
Founders
2
Total funds raised
€6.5M
Rounds
3
Investors
6
Last round
Oct 2023
SectorsBiotechnology, Diagnostics, Longevity, Genomics Start-up MapHealthtech & Bio › Diagnostics & precision medicine testing

Suggest a correction

Founders

María Blasco Marhuenda
Co-founder & Chief Scientific Advisor
Stephen J. Matlin
Co-founder & CEO

Global models 3

Hurdle
United Kingdom · www.hurdle.bio ↗
Sells biological-age and biomarker tests to consumers through partners, and provides diagnostics infrastructure to health and pharma companies. This matches Life Length's split between consumers and business clients.
$20MComparable
Telomere Diagnostics
United States · www.teloyears.com ↗
Sells telomere-length testing (TeloYears) to consumers and physicians as a biological-age test, and offers telomere measurement to researchers. It is Life Length's closest direct peer.
$15MComparable
Tally Health
United States · tallyhealth.com ↗
Sells biological-age testing to consumers based on a molecular ageing biomarker (epigenetic rather than telomere), which mirrors Life Length's direct-to-consumer ageing tests.
$10MComparable

In the same niche 48 others

See all in the Start-ups Map →

Notes: Most funded first

Investors 6

Open as list →
Fundación Botín
www.fundacionbotin.org
Investor Spain
Carlos Genzor
Led Series A 2023 Spain
Grupo Alter
Led Seed 2018 HQ unknown
Yamada Bee Company
Led Seed 2014 Japan
Óscar Landeta
Led Series A 2023 Spain
Matlin Associates
Investor United States

Funding rounds 3

DateRoundAmountLead
Start typing to search across everything.
↑↓ navigate↵ openesc close? shortcuts
Keyboard shortcuts
/ Ctrl K
Search
j k
Next or previous row
↵
Open the row
Ctrl ↵
Open it in a new tab
[ ]
Previous or next page
?
This list